The rise and rise of Global Pharma Excipients Market

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Sarclisa by Sanofi has EC Approval to Treat Multiple Myeloma

In order to treat multiple myeloma in adults, Sarclisa...

Hengrui Pharma and GSK Ink Agreement on 12 Innovative Drugs

In a recent move, Hengrui Pharma and GSK have...

Law to Decentralize Personalized Drug Manufacturing in UK

A legislation to decentralize personalized drug manufacturing in UK...

Magnetic Particles Steer the Vesicles for Drug Delivery

Researchers have gone on to demonstrate that microscopic drug...

With the rise in the Global Pharma Industry, excipients too are bound to have their share of light. Of late, there has been an increasing demand for generic drugs which has, in turn, led to a rise of the excipients market. Also, there has been a steep rise in chronic disease cases as well. Not only that, but the rise in pharma excipients market can also be attributed to the Biopharmaceutical sector which has shown a lot of promise.

Global pharmaceutical excipients market is expected to reach USD 9.78 Billion by 2025, at a CAGR of 5.93% from 2018 to 2025. Europe has emerged as the largest excipient market with 41.53% market share. Presence of a substantial elderly population can be termed as one of the driving force in making this region a stronghold for excipients.

Asia too has emerged as one of the rising markets for excipients due to growth in the pharmaceutical manufacturing industry. Countries like China and India that drive the Asian pharma market are expected to give an immense push to regional CAGR which by the will be highest across the world standing at a growth of 8.09%.

Latest stories

Related stories

Sarclisa by Sanofi has EC Approval to Treat Multiple Myeloma

In order to treat multiple myeloma in adults, Sarclisa...

Hengrui Pharma and GSK Ink Agreement on 12 Innovative Drugs

In a recent move, Hengrui Pharma and GSK have...

Law to Decentralize Personalized Drug Manufacturing in UK

A legislation to decentralize personalized drug manufacturing in UK...

Magnetic Particles Steer the Vesicles for Drug Delivery

Researchers have gone on to demonstrate that microscopic drug...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back